InvestorsHub Logo
Followers 116
Posts 1877
Boards Moderated 0
Alias Born 11/22/2017

Re: ATLnsider post# 315347

Thursday, 10/08/2020 2:06:02 PM

Thursday, October 08, 2020 2:06:02 PM

Post# of 700711
ATLnsider,

Wow, thank you!

Today the German version has not yet been adjusted but I expect an adjustment one of the following days.

E.2 Objective of the trial
E.2.1 Main objective of the trial
The primary objective of this study is to compare progression free
survival (PFS) between patients in the DCVax-L cohort and patients in
the placebo cohort in patients with no evidence of disease progression at
baseline.
E.2.2 Secondary objectives of the trial
The secondary objective of this study is to compare Overall Survival (OS)
between patients in the DCVax-L group and patients in the placebo
group in patients with no evidence of disease progression at baseline.


https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001977-13/DE#summary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News